Navigation Links
Investigation to Show Harassment, Legal Restrictions Impose Severe Obstacles for Abortion Providers and Women Seeking Abortions
Date:7/13/2009

NEW YORK, July 13 /PRNewswire-USNewswire/ -- Next week, the Center for Reproductive Rights will release the results of an investigation of abortion clinics in six states demonstrating that attacks, harassment, discriminatory legal restrictions and stigma are causing a shortage of abortion facilities and providers, severely limiting women's reproductive rights. The report will be released at a briefing for members of Congress, staff and media on Wednesday, July 22, at 12:30 p.m. in room HC-8 of the U.S. Capitol.

The report -- which studied clinics in Alabama, Mississippi, Missouri, North Dakota, Pennsylvania and Texas -- calls for urgent action by governments at all levels, law enforcement, the medical community and the public to recognize abortion providers as human rights defenders who protect women's fundamental rights.

WHAT: Congressional Briefing: Defending Human Rights: Abortion Providers Facing Threats, Restrictions and Harassment

WHO: Rep. Jerrold Nadler (D-NY)

Rep. Jan Schakowsky (D-IL)

Nancy Northup, Center for Reproductive Rights

Marianne Mollman, Human Rights Watch

Amy Hagstrom Miller, Whole Woman's Health

WHEN: 12:30 p.m. - 2:00 p.m., Wednesday, July 22, 2009

WHERE: Room HC - 8 US Capitol

The Center for Reproductive Rights is a global legal organization dedicated to advancing women's reproductive health, self-determination and dignity as basic human rights.


'/>"/>
SOURCE Center for Reproductive Rights
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
3. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
4. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
7. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
8. UGA vet school receives $1.18 million NIH grant for rabies vaccine investigations
9. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
10. Accentia announces investigational new drug application for Revimmune for refractory MS
11. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
Breaking Medicine Technology: